Literature DB >> 7338536

DNCB skin test in cases of malignant melanoma.

E Ehring, H Loth.   

Abstract

Two hundred sixty-nine patients suffering from malignant melanoma were sensitized with DNCB acetone solution. The intensity of the skin reaction was normally independent of both the current stage and the further progression of the disease.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7338536     DOI： 10.1007/bf00410670

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  7 in total

1.  [The immunological status in malignant melanoma].

Authors:  E Heid; P Bigel; O G Robez
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1975

2.  [Sensibilization rate with haptenes in patients with neoplasms].

Authors:  W Remy; B Russmann; G Stüttgen
Journal:  Med Welt       Date:  1974-10-25

3.  [Immunotherapy].

Authors:  F J Lejeune; J L Bernheim; R Vanwijck
Journal:  Acta Chir Belg       Date:  1974-03       Impact factor: 1.090

4.  [Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].

Authors:  I Schneider; H Aulepp; H Gartmann
Journal:  Z Hautkr       Date:  1976-02-01

5.  Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.

Authors:  F R Eilber; J A Nizze; D L Morton
Journal:  Cancer       Date:  1975-03       Impact factor: 6.860

6.  Effect of BCG (Tice strain) on primary sensitization to 2,4-dinitrochlorobenzene and on established delayed hypersensitivity in human malignant melanoma.

Authors:  G M Mavligit; J U Gutterman; E M Hersh
Journal:  J Natl Cancer Inst       Date:  1976-10       Impact factor: 13.506

7.  [Treatment of malignant melanoma with dinitrochlorobenzene ointment].

Authors:  H Loth; F Ehring
Journal:  Hautarzt       Date:  1978-03       Impact factor: 0.751
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.